A5 Labs Expands Board of Directors and Management Team

MONTREAL, QUEBEC--(Marketwire - August 10, 2010) - A5 Laboratories Inc. (A5 Labs) (OTCBB: AFLB) today announced the appointment of Dr. Gisele Matni M.Sc., Ph.D. to the board of directors and to the position of V.P. Operations. Dr. Matni holds a doctorate in Pharmacy, a master degree in Biochemistry from University of Montreal and a Ph.D. in Analytical chemistry from McGill University.

Dr. Matni brings over 15 years experience in management of pharmaceutical and biotechnology related projects, including in-vitro potency analysis of interferon based products. In addition she has extensive knowledge in identification, specification, extraction, separation and analyses of actives proteins from various source of materials and pharmaceutical drugs.

Dr. Matni has held research scientist positions at Environment Canada where she worked on Microwave-Assisted Process technology as well as senior management positions at Actilab Pharma as director of laboratory operations, quality control/quality assurance of pharmaceutical analyses.

About A5 Labs:

A5 Labs is a contract research based organization servicing the pharmaceutical and biotechnology companies in North America. The company utilizes its research capabilities to license and acquire novel biotechnology products for development and commercialization.

Safe Harbor Statement:

Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, as they relate to A5 or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors such as the level of business and consumer spending, the amount of sales of A5’s products, the competitive environment within the industry, the ability of A5 to continue to expand its operations, the level of costs incurred in connection with A5’s expansion efforts, economic conditions in the industry and the financial strength of A5’s customers and suppliers. A5 does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.